Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-19-030039

EVP, Chief Financial Officer sold 7,164 shares at an average $125.80 ($901,198)

  • EVP, Chief Financial Officer acquired 5,718 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Burke William P. Mr. · EVP, Chief Financial Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2019-10-01 Exercise or conversion : show line 1 in the form +5,718 $41.64 $238,098 20,178 D
2019-10-01 Sale : show line 2 in the form −3,070 $124.47 $382,123 17,108 D
2019-10-01 Sale : show line 3 in the form −1,309 $125.71 $164,554 15,799 D
2019-10-01 Sale : show line 4 in the form −1,670 $126.72 $211,622 14,129 D
2019-10-01 Sale : show line 5 in the form −648 $127.80 $82,814 13,481 D
2019-10-01 Sale : show line 6 in the form −467 $128.66 $60,084 13,014 D
Open-market sales · 7,164 sh · avg $125.80 · $901,198

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-10-01 Exercise or conversion : show line 7 in the form Non-qualified Stock Option (Right to Buy) −5,718 11,435 D
Loading xslF345X03/form4.xml…